Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
AHVLA announce new chief executive
Chris Hadkiss takes up post in the new year

The Animal Health and Veterinary Laboratories Agency (AHVLA) has announced the appointment of a new chief executive who will begin on January 7, 2013.

Chris Hadkiss, previously executive director at the Forensic Science Service (FSS), will become part of the AHVLA team, welcomed by the 2,500 members of staff.

At his previous post, Hadkiss was responsible for all aspects of operational and commercial activity of forensic operations within the UK and overseas. Hadkiss has a long and distinguished career in forensic science, having started as an assistant scientist at the Metropolitan Police laboratory in 1979.

In 2003 he was appointed general manager of FSS’s London site, and subsequently regional general manager, with responsibility for the south of England. He became director of operations in 2007 and was appointed to the board as executive director in January 2008.

Commenting on his new role, Hadkiss said: “I look forward to leading AHVLA and working with our stakeholders and partners to support a healthy and sustainable food and farming industry across Great Britain, and safeguard society from animal disease threats.”


Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.